Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of 0.05% cyclosporin ophthalmic
emulsion (Restasis) in patients with Stevens-Johnson syndrome that have dry eyes by
subjective symptoms and signs.